Ndị na-anabata Glutamate n'ime usoro ọgwụ mgbochi Mesolimbic System Mediate Alcohol Relapse Character (2015)

J Neurosci. 2015 Nov 25;35 (47):15523-38. doi: 10.1523/JNEUROSCI.2970-15.2015.

Eisenhardt M1, Leixner S1, Luján R2, Spanagel R3, Bilbao A4.

nkịtị

Ntinye Glutamatergic n'ime ụzọ mesolimbic dopamine (DA) na-arụ ọrụ dị oke mkpa na mmepe nke omume riri ahụ. Ọ bụ ezie na nke a kwadoro nke ọma maka ụfọdụ ọgwụ ọjọọ eme ihe, a maghị ma ndị na-anabata glutamate n'ime usoro mesolimbic na-etinye aka n'ịgbado ihe na-eri ahụ nke ịṅụ mmanya na-adịghị ala ala.

N'ebe a, anyị tụlere ntinye nke mesolimbic NMDARs na AMPARs na nzaghachi na-achọ mmanya na-achọ mmanya na-akpata site na mkpali gburugburu ebe obibi na omume nlọghachi azụ site na iji ahịrị mutant mutant anọ na-enweghị mkpụrụ ndụ ihe nketa glutamate Grin1 ma ọ bụ Gria1 ma ọ bụ DA transporter (DAT) ma ọ bụ D1R na-egosipụta akwara. Anyị na-ebu ụzọ gosipụta enweghị GluN1 ma ọ bụ GluA1 na DAT- ma ọ bụ D1R na-egosipụta neurons na ahịrị òké anyị mutant site na ọmụmụ ihe. Anyị na-egosikwa na subunits GluN1 na GluA1 ndị na-anabata ya n'ime mpaghara mpaghara neuronal ndị a na-emezi mmetụta enweghị mmanya na-aba n'anya, ebe enweghị mmetụta na onodu ya - gbakwunyere na-ebute iweghachi omume ịchọ mmanya. Anyị na-akwadokwa nsonaazụ ndị a n'ụzọ ọgwụ site n'igosipụta mbelata yiri nke mmanya na-aba n'anya mgbe ntinye nke NMDAR antagonist memantine n'ime nucleus accumbens na ventral tegmental area of ​​control ụmụ oke, yana nnapụta nke mutant phenotype site na ike pharmacological nke ọrụ AMPAR site na iji aniracetam. INkwubi okwu, neurons dopamine yana D1R na-egosipụta neurons spiny ọkara yana ntinye glutamatergic site na NMDARs na AMPARs na-eme ihe na egwu iji mebie nzaghachi nlọghachi azụ. Nsonaazụ ndị a na-enye mkpụrụ ndụ neuroanatomical na molekụla maka omume nlọghachi azụ ma mesie mkpa ọgwụ glutamatergic dị n'ịgbanwe omume nlọghachi azụ.

AKWIGNKWỌ MAKA:

N'ebe a, anyị na-enye ihe akaebe mkpụrụ ndụ ihe nketa na ọgwụ na ndị na-anabata glutamate n'ime usoro mesolimbic dopamine na-ekere òkè dị mkpa na nlọghachi mmanya. N'iji ụdị ụdị òké transgenic dị iche iche na saịtị dị iche iche na nnwale nkwado ọgwụ, anyị na-egosi na akụkụ dị egwu nke NMDARs na AMPAR gosipụtara ma ọ bụ na neurons dopamine ma ọ bụ na dopamine receptor D1-nwere neurons na-ekere òkè dị mkpa na mmetụta mmanya na-aba n'anya (mmụba na ịṅụ mmanya na-aba n'anya mgbe oge nkwụsịtụ gasịrị) ebe ọ na-enweghị mmetụta na ihe ndị gbara ya gburugburu- gbakwunyere na-akpata iweghachite nzaghachi na-achọ mmanya. Ọgwụ ndị na-ezubere glutamatergic neurotransmission site na nhọrọ arụghị ọrụ nke ndị na-anabata glutamate ndị a nwere ike ịnwe nrụpụta ọgwụgwọ.